Table 1. Management of reported decreased fetal movements.

Study	Intervention A	Subgroup with decreased fetal movements/whole group n/N (%)	Intervention B	Subgroup with decreased fetal movements/whole group n/N (%)	Outcome	Main outcomes for whole group
						Group A	Group B	RR (95% CI)
Computerised interpretation
Bracero 1999	Visual interpretation	21/205 (10%)	Computerised interpretation	23/205 (11%)	Perinatal mortality and severe morbidity	20/201	11/204	1.85 [0.91 to 3.75]
					Caesarean section	NA	NA
					Perinatal mortality alone	1/201	0/204	3.04 [0.12 to 74.30]
Doppler
Burke 1992	Doppler	9/241 (4%)	Control	16/235(7%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	58/241	51/235	1.11 [0.80 to 1.54]
					Perinatal mortality alone	4/241	3/235	1.11 [0.80 to 1.54]
Hofmeyr 1991	Doppler	49/438 (11%)	Fetal heart rate	65/459 (14%)	Perinatal mortality and severe morbidity	70/438	77/459	0.95 [0.71 to 1.28]
					Caesarean section	107/438	123/459	0.91 [0.73 to 1.14]
					Perinatal mortality alone	4/438	8/459	0.52 [0.16 to 1.73]
Johnstone 1993	Doppler group	157/1114 (14%)	Non-Doppler group	181/1175 (15%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	170/1114	198/1175	0.91 [0.75 to 1.09]
					Perinatal mortality alone	NA	NA
Williams 2003	Doppler group	147/649 (23%)	Non-stress test group	162/691 (23%)	Perinatal mortality and severe morbidity	16/649	24/691	0.71 [0.38 to 1.32]
					Caesarean section	183/649	223/691	0.87 [0.74 to 1.03]
					Perinatal mortality alone	0/649	1/691	0.35 [0.01 to 8.70]
Biophysical profile
Jamal 2007	Modified biophysical profile	18/96 (19%)	Biophysical profile	8/104 (8%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	1/96	1/104	1.08 [0.07 to 17.08]
					Abnormal test results	30/96	24/104	1.52 [0.81 to 2.84]
Manning 1984	Biophysical profile scoring group,	16/375 (4%)	Non-stress testing scheme group	13/360(4%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	4/375	4/360	0.96 [0.24 to 3.81]
					Abnormal test result	23/375	61/360	0.32 [0.19 to 0.53]
Sood 2007	Modified biophysical profile following vibroacoustic stimulation group	15/110 (14%)	Mock stimulation group	13/104 (13%)	Perinatal mortality and morbidity	4/110	8/104	0.47 [0.15 to 1.52]
					Caesarean section	NA	NA
					Perinatal mortality alone	2/110	3/104	0.63 [0.11 to 3.70]
					Abnormal test result	3/110	7/104	0.41 [0.11 to 1.53] first)
Acoustic stimulation
Newnham 1990	Fetal acoustic stimulation group	17/90 (19%)	Non-stress testing scheme group	13/82 (16%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	0/90	0/82	Not estimable
					Non-reactive CTG	17/150*	25/150*	0.64 [0.33 to 1.24]
Sleutel 1990	Single 5 second vibroacoustic stimulus group	1/23 (4%)	Intermittent vibroacoustic stimuli group	5/22 (23%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	NA	NA
Smith 1986	Fetal acoustic stimulation group	63/366 (17%)	Non-stress test group	49/349 (14%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	0/366	1/349	0.32 [0.01 to 7.78]
					Non-reactive test	78/858*	122/869*	0.61 [0.45 to 0.83]
Tongsong 1994	Fetal acoustic stimulation group	128/635 (20%)	Non-stress test group	129/638 (20%)	Perinatal mortality and severe morbidity	NA	NA
					Caesarean section	NA	NA
					Perinatal mortality alone	NA	NA
					Non-reactive CTG	43/635*	88/638*	0.49 [0.35 to 0.70]

In May 2011 the lead authors on each of the following trials were contacted regarding the availability of outcomes specifically for cases admitted to the trial with decreased fetal movements. Data for this subgroup were available only for the 28 cases in Sood 2007. The data above refers to the whole sample in each trial.

^*NB refers to number of tests, not women